{"id":22435,"date":"2023-03-21T10:29:13","date_gmt":"2023-03-21T17:29:13","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/?p=22435"},"modified":"2025-07-17T09:29:17","modified_gmt":"2025-07-17T16:29:17","slug":"velcade-bortezomib-a-promising-treatment-for-multiple-myeloma","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/velcade-bortezomib-a-promising-treatment-for-multiple-myeloma\/","title":{"rendered":"Velcade (Bortezomib)\uff1a\u4e00\u79cd\u6709\u524d\u666f\u7684\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u6cbb\u7597\u65b9\u6cd5"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u662f\u4e00\u79cd\u5728\u4e16\u754c\u8bb8\u591a\u5730\u533a\u666e\u904d\u5b58\u5728\u7684\u764c\u75c7\u3002\u8fd9\u79cd\u75be\u75c5\u4f1a\u5f71\u54cd\u9aa8\u9ad3\u4e2d\u7684\u6d46\u7ec6\u80de\uff0c\u572860\u5c81\u4ee5\u4e0a\u7684\u7537\u6027\u4e2d\u5f88\u5e38\u89c1\u3002\u5982\u679c\u4e0d\u53ca\u65f6\u6cbb\u7597\uff0c\u53ef\u80fd\u4f1a\u81f4\u547d\u3002&nbsp;<\/span><\/p>\n\n\n\n<div  id=\"call-to-action-77464d26dd6536fbc784bfab0efda8e0\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\t\u4e0e\u4e13\u5bb6\u4ea4\u8c08 \t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\t\u5173\u4e8e\u5171\u4ed8\u989d\u63f4\u52a9\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<p><span style=\"font-weight: 400;\">\u9aa8\u9ad3\u662f\u4eba\u4f53\u8d1f\u8d23\u4ea7\u751f\u5404\u79cd\u8840\u7ec6\u80de\u7684\u5668\u5b98\u3002\u5f53\u9aa8\u9ad3\u53d7\u5230\u764c\u75c7\u5f71\u54cd\u65f6\uff0c\u4ea7\u751f\u7684\u5f02\u5e38\u7ec6\u80de\u4f1a\u6269\u6563\u5230\u8eab\u4f53\u5176\u4ed6\u90e8\u4f4d\uff0c\u56e0\u6b64\u5f97\u540d\u201c\u591a\u53d1\u6027\u201d\u9aa8\u9ad3\u7624\u3002&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">\u5c3d\u7ba1\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u662f\u4e00\u79cd\u5371\u53ca\u751f\u547d\u7684\u75be\u75c5\uff0c\u4f46\u7814\u7a76\u8868\u660e\uff0c\u4e00\u79cd\u836f\u7269\u53ef\u4ee5\u6709\u6548\u63a7\u5236\u5176\u75c7\u72b6\uff0c\u5e76\u5e2e\u52a9\u60a3\u8005\u66f4\u8212\u9002\u5730\u751f\u6d3b\u3002\u672c\u6587\u5c06\u63a2\u8ba8\u8fd9\u79cd\u836f\u7269\u2014\u2014\u4e07\u73c2\uff08\u787c\u66ff\u4f50\u7c73\uff09\uff0c\u4ee5\u53ca\u5b83\u7684\u6cbb\u7597\u65b9\u6848\u3001\u7ed9\u836f\u65b9\u6cd5\u3001\u5242\u91cf\u3001\u526f\u4f5c\u7528\u548c\u53ef\u80fd\u7684\u8d39\u7528\u3002<\/span><\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"\u5207\u6362\u76ee\u5f55\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">\u5207\u6362<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/velcade-bortezomib-a-promising-treatment-for-multiple-myeloma\/#What_Is_Velcade\" >Velcade \u662f\u4ec0\u4e48\uff1f<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/velcade-bortezomib-a-promising-treatment-for-multiple-myeloma\/#What_Is_Velcade_Used_For\" >Velcade \u7684\u7528\u9014\u662f\u4ec0\u4e48\uff1f<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/velcade-bortezomib-a-promising-treatment-for-multiple-myeloma\/#How_Does_It_Work\" >\u5b83\u662f\u5982\u4f55\u5de5\u4f5c\u7684\uff1f<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/velcade-bortezomib-a-promising-treatment-for-multiple-myeloma\/#Drug_Administration\" >\u836f\u54c1\u7ba1\u7406\u5c40<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/velcade-bortezomib-a-promising-treatment-for-multiple-myeloma\/#Velcade_Side_Effects\" >Velcade \u526f\u4f5c\u7528<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/velcade-bortezomib-a-promising-treatment-for-multiple-myeloma\/#Cost\" >\u6210\u672c<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\" id=\"h-what-is-velcade\"><span class=\"ez-toc-section\" id=\"What_Is_Velcade\"><\/span>Velcade \u662f\u4ec0\u4e48\uff1f<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">\u4e07\u73c2\uff08Velcade\uff09\u662f\u4e00\u79cd\u7528\u4e8e\u6cbb\u7597\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u548c\u5957\u7ec6\u80de\u6dcb\u5df4\u7624\u7b49\u764c\u75c7\u7684\u6297\u764c\u836f\u7269\u3002\u8be5\u836f\u7269\u901a\u5e38\u7528\u4e8e\u6cbb\u7597\u7ecf\u591a\u79cd\u7597\u6cd5\u540e\u75c5\u60c5\u4ecd\u672a\u6539\u5584\u7684\u60a3\u8005\u3002\u8be5\u836f\u7269\u901a\u8fc7\u6740\u6b7b\u764c\u7ec6\u80de\u8d77\u6548\u3002&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">\u8be5\u836f\u7269\u4e8e1995\u5e74\u7531Myogenics\u516c\u53f8\u9996\u6b21\u751f\u4ea7\uff0c\u5f53\u65f6\u88ab\u79f0\u4e3aPS-341\u3002\u4e3a\u4e86\u8bc1\u660e\u5176\u7597\u6548\uff0c\u540c\u5e74\u5728\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u60a3\u8005\u8eab\u4e0a\u8fdb\u884c\u4e86\u4e00\u9879\u5c0f\u89c4\u6a21\u76841\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002\u7531\u4e8e\u7ed3\u679c\u79ef\u6781\uff0c\u5343\u79a7\u5236\u836f\u516c\u53f8\u4e8e1999\u5e74\u5c06\u5176\u7528\u4e8e\u8fdb\u4e00\u6b65\u7684\u4e34\u5e8a\u8bd5\u9a8c\u3002&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">\u7136\u800c\uff0c\u76f4\u5230 2003 \u5e74\uff0c\u4e5f\u5c31\u662f\u5408\u6210 8 \u5e74\u540e\uff0c\u5b83\u624d\u5f97\u5230 <\/span><a href=\"https:\/\/www.fda.gov\/drugs\/postmarket-drug-safety-information-patients-and-providers\/velcade-bortezomib-information#:~:text=The%20Food%20and%20Drug%20Administration,on%20the%20most%20recent%20therapy.\"><span style=\"font-weight: 400;\">\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\u7684\u6279\u51c6<\/span><\/a><span style=\"font-weight: 400;\"> \u5728\u7f8e\u56fd\uff0c\u787c\u66ff\u4f50\u7c73\u5df2\u88ab\u6279\u51c6\u7528\u4e8e\u6cbb\u7597\u96be\u6cbb\u6027\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u30022005\u5e74\uff0c\u787c\u66ff\u4f50\u7c73\u8fd8\u83b7\u5f97FDA\u6279\u51c6\uff0c\u7528\u4e8e\u6cbb\u7597\u81f3\u5c11\u63a5\u53d7\u8fc7\u4e00\u79cd\u65e2\u5f80\u7597\u6cd5\u7684\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u60a3\u8005\uff1b2008\u5e74\uff0c\u787c\u66ff\u4f50\u7c73\u88ab\u6279\u51c6\u7528\u4e8e\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u60a3\u8005\u7684\u521d\u59cb\u6cbb\u7597\u3002&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">\u6700\u7ec8\uff0c\u8be5\u836f\u7269\u4e8e 2014 \u5e74 8 \u6708\u83b7\u6279\u7528\u4e8e\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u60a3\u8005\u7684\u518d\u6cbb\u7597\uff0c\u5e76\u4e8e 2014 \u5e74 10 \u6708\u83b7\u6279\u7528\u4e8e\u6cbb\u7597\u5957\u7ec6\u80de\u6dcb\u5df4\u7624\u3002Bortezomib \u53ef\u4ee5\u5355\u72ec\u670d\u7528\uff0c\u4e5f\u53ef\u4ee5\u4e0e\u5176\u4ed6\u6297\u764c\u836f\u7269\uff08\u5982\u7f8e\u6cd5\u4ed1\u3001\u8102\u8d28\u4f53\u963f\u9709\u7d20\u3001\u5e15\u6bd4\u53f8\u4ed6\u548c <a href=\"https:\/\/www.thalidomidetrust.org\/about-us\/about-thalidomide\/\">\u6c99\u5229\u5ea6\u80fa<\/a>. \u4e5f\u53ef\u4ee5\u4e0e\u6cfc\u5c3c\u677e\u9f99\u7b49\u7c7b\u56fa\u9187\u4e00\u8d77\u670d\u7528\u3002&nbsp;<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-what-is-velcade-used-for\"><span class=\"ez-toc-section\" id=\"What_Is_Velcade_Used_For\"><\/span>Velcade \u7684\u7528\u9014\u662f\u4ec0\u4e48\uff1f<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Bortezomib \u7528\u4e8e\u6cbb\u7597\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u548c\u5957\u7ec6\u80de\u6dcb\u5df4\u7624\u3002\u8fd9\u4e24\u79cd\u75be\u75c5\u90fd\u5c5e\u4e8e\u764c\u75c7\uff0c\u8be5\u836f\u7269\u7684\u4f5c\u7528\u673a\u5236\u662f\u6740\u6b7b\u764c\u7ec6\u80de\uff0c\u7f13\u89e3\u75c5\u60c5\u3002\u7136\u800c\uff0c\u9700\u8981\u6ce8\u610f\u7684\u662f\uff0c\u8be5\u836f\u7269\u5e76\u4e0d\u80fd\u6cbb\u6108\u4efb\u4f55\u4e00\u79cd\u75be\u75c5\uff0c\u5b83\u53ea\u80fd\u8d77\u5230\u6cbb\u7597\u548c\u8f85\u52a9\u7f13\u89e3\u7684\u4f5c\u7528\u3002&nbsp;<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-how-does-it-work\"><span class=\"ez-toc-section\" id=\"How_Does_It_Work\"><\/span>\u5b83\u662f\u5982\u4f55\u5de5\u4f5c\u7684\uff1f<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"420\" height=\"236\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/velcade-patient2.jpg\" alt=\"Patient receiving Velcade treatment for multiple myeloma.\" class=\"wp-image-26120\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/velcade-patient2.jpg 420w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/velcade-patient2-300x169.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/velcade-patient2-86x48.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/velcade-patient2-167x94.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/velcade-patient2-280x157.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/velcade-patient2-370x208.jpg 370w\" sizes=\"auto, (max-width: 420px) 100vw, 420px\" \/><\/figure>\n<\/div>\n\n\n<p><span style=\"font-weight: 400;\">Bortezomib \u5c5e\u4e8e\u4e00\u7c7b\u88ab\u79f0\u4e3a\u86cb\u767d\u9176\u4f53\u6291\u5236\u5242\u7684\u6297\u764c\u836f\u7269\u3002\u5b83\u53ef\u4ee5\u9650\u5236\u548c\u963b\u6b62\u4eba\u4f53\u7ec6\u80de\u4e2d\u86cb\u767d\u9176\u4f53\u7684\u751f\u957f\u3002&nbsp;&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">\u86cb\u767d\u9176\u4f53\u5b58\u5728\u4e8e\u7ec6\u80de\u4e2d\uff0c\u5176\u4e3b\u8981\u529f\u80fd\u662f\u5206\u89e3\u7ec6\u80de\u4e0d\u9700\u8981\u7684\u86cb\u767d\u8d28\u3002\u56e0\u6b64\uff0c\u4f7f\u7528\u86cb\u767d\u9176\u4f53\u6291\u5236\u5242\u4f1a\u963b\u6b62\u86cb\u767d\u9176\u4f53\u53d1\u6325\u5176\u529f\u80fd\uff0c\u5bfc\u81f4\u86cb\u767d\u8d28\u5728\u7ec6\u80de\u5185\u79ef\u805a\uff0c\u5bfc\u81f4\u7ec6\u80de\u6b7b\u4ea1\u3002&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">\u5bf9\u4e8e\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u548c\u5957\u7ec6\u80de\u6dcb\u5df4\u7624\u60a3\u8005\uff0c\u787c\u66ff\u4f50\u7c73\u9776\u5411\u764c\u7ec6\u80de\uff0c\u56e0\u4e3a\u764c\u7ec6\u80de\u5bf9\u787c\u66ff\u4f50\u7c73\u7684\u4f5c\u7528\u66f4\u4e3a\u654f\u611f\u3002\u787c\u66ff\u4f50\u7c73\u963b\u6b62\u8fd9\u4e9b\u7ec6\u80de\u4e2d\u7684\u86cb\u767d\u9176\u4f53\u53d1\u6325\u5176\u529f\u80fd\uff0c\u4ece\u800c\u5bfc\u81f4\u764c\u7ec6\u80de\u6b7b\u4ea1\u3002&nbsp;<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-drug-administration\"><span class=\"ez-toc-section\" id=\"Drug_Administration\"><\/span>\u836f\u54c1\u7ba1\u7406\u5c40<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Bortezomib \u901a\u5e38\u901a\u8fc7\u76ae\u4e0b\u6ce8\u5c04\u6216\u9759\u8109\u6ce8\u5c04\u7ed9\u836f\u3002\u76ae\u4e0b\u6ce8\u5c04\u53ef\u4ee5\u5728\u5927\u817f\u6216\u8179\u90e8\u8fdb\u884c\u3002\u65e0\u8bba\u6ce8\u5c04\u90e8\u4f4d\u5728\u54ea\u91cc\uff0c\u6bcf\u6b21\u6ce8\u5c04\u540e\u90fd\u5e94\u66f4\u6362\u6ce8\u5c04\u90e8\u4f4d\uff0c\u4ee5\u51cf\u5c11\u75bc\u75db\u548c\u76ae\u80a4\u635f\u4f24\u3002&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">\u8be5\u836f\u7269\u6bcf\u5468\u7ed9\u836f\u4e24\u6b21\uff0c\u6301\u7eed\u4e24\u5468\u3002\u4e24\u5468\u540e\uff0c\u505c\u836f13\u5929\uff0c\u5b8c\u6210\u4e09\u5468\u7684\u7597\u7a0b\u3002\u60a8\u5c06\u5b8c\u6210\u4ee5\u4e0b\u6cbb\u7597\u5468\u671f <\/span><span style=\"font-weight: 400;\">\u6700\u591a 8 \u4e2a\u5faa\u73af\u3002<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">\u5982\u679c\u60a8\u4f53\u5185\u8840\u6e05M\u86cb\u767d\uff08\u4e00\u79cd\u7531\u9aa8\u9ad3\u7624\u7ec6\u80de\u4ea7\u751f\u7684\u86cb\u767d\u8d28\uff09\u6c34\u5e73\u964d\u4f4e\uff0c\u5219\u8868\u660e\u6cbb\u7597\u6709\u6548\uff0c\u60a8\u9700\u8981\u5b8c\u6210\u53e6\u5916\u4e24\u4e2a\u6cbb\u7597\u5468\u671f\u3002\u5982\u679c\u8840\u6e05M\u86cb\u767d\u6c34\u5e73\u6ca1\u6709\u663e\u8457\u964d\u4f4e\uff0c\u5219\u9700\u8981\u7ee7\u7eed\u5b8c\u6210\u53e6\u5916\u516b\u4e2a\u6cbb\u7597\u5468\u671f\u3002\u7136\u800c\uff0c\u4e0d\u540c\u60a3\u8005\u7684\u6cbb\u7597\u5468\u671f\u53ef\u80fd\u4f1a\u6839\u636e\u75c5\u60c5\u4e25\u91cd\u7a0b\u5ea6\u800c\u6709\u6240\u4e0d\u540c\u3002\u56e0\u6b64\uff0c\u60a8\u7684\u533b\u751f\u5c06\u786e\u5b9a\u6700\u9002\u5408\u60a8\u7684\u6cbb\u7597\u65b9\u6848\u3002<\/span><\/p>\n\n\n\n<div  id=\"call-to-action-0f3ced3a3f7d862d1b674fa3dcb084ce\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\t\u83b7\u5f97\u5171\u4ed8\u989d\u63f4\u52a9\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\t\u7ecf\u6d4e\u63f4\u52a9\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"#form\">\u5b89\u6392\u54a8\u8be2<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-velcade-side-effects\"><span class=\"ez-toc-section\" id=\"Velcade_Side_Effects\"><\/span>Velcade \u526f\u4f5c\u7528<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">\u4f7f\u7528\u787c\u66ff\u4f50\u7c73\u7684\u4e00\u4e9b\u526f\u4f5c\u7528\u5305\u62ec\uff1a<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">\u5f31\u70b9&nbsp;<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">\u4fbf\u79d8<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">\u6076\u5fc3<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">\u5934\u6655<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">\u5455\u5410<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">\u98df\u6b32\u4e0d\u632f<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">\u75bc\u75db<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">\u5934\u75db<\/span><\/li>\n<\/ul>\n\n\n\n<p><span style=\"font-weight: 400;\">\u5728\u6781\u7aef\u60c5\u51b5\u4e0b\uff0c\u53ef\u80fd\u4f1a\u51fa\u73b0\u4e25\u91cd\u7684\u6076\u5fc3\u3001\u8179\u6cfb\u548c\u5455\u5410\u3002\u4e00\u65e6\u51fa\u73b0\u4e25\u91cd\u7684\u526f\u4f5c\u7528\uff0c\u8bf7\u7acb\u5373\u8054\u7cfb\u836f\u5242\u5e08\u6216\u533b\u751f\u3002&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">\u4f7f\u7528\u8be5\u836f\u7269\u540e\u53ef\u80fd\u4f1a\u9047\u5230\u7684\u53e6\u4e00\u4e2a\u7279\u6b8a\u526f\u4f5c\u7528\u662f <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3437249\/#:~:text=The%20tumor%20lysis%20syndrome%20occurs,hyperkalemia%2C%20hyperphosphatemia%2C%20and%20hypocalcemia.\">\u80bf\u7624\u6eb6\u89e3\u7efc\u5408\u5f81<\/a>\u3002\u8fd9\u79cd\u526f\u4f5c\u7528\u662f\u7531\u4e8e\u764c\u7ec6\u80de\u88ab\u5feb\u901f\u7834\u574f\u800c\u4ea7\u751f\u7684\u3002\u4e3a\u4e86\u964d\u4f4e\u8fd9\u79cd\u526f\u4f5c\u7528\u7684\u98ce\u9669\uff0c\u5efa\u8bae\u60a8\u591a\u559d\u6c34\uff0c\u5e76\u6309\u7167\u6307\u793a\u670d\u7528\u5176\u4ed6\u63a8\u8350\u836f\u7269\u3002&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">\u8d2b\u8840\u662f\u670d\u7528\u787c\u66ff\u4f50\u7c73\u540e\u53ef\u80fd\u51fa\u73b0\u7684\u53e6\u4e00\u4e2a\u526f\u4f5c\u7528\u3002\u8fd9\u662f\u56e0\u4e3a\u8be5\u836f\u7269\u53ef\u80fd\u4f1a\u51cf\u5c11\u4f53\u5185\u7ea2\u7ec6\u80de\u7684\u6570\u91cf\u3002\u8fd9\u79cd\u526f\u4f5c\u7528\u4f1a\u5bfc\u81f4\u8eab\u4f53\u611f\u5230\u75b2\u5026\u548c\u865a\u5f31\u3002<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">\u6700\u540e\uff0c\u76ae\u75b9\u662f\u4f7f\u7528\u8be5\u836f\u7269\u7684\u53e6\u4e00\u4e2a\u526f\u4f5c\u7528\u3002\u4e0d\u8fc7\uff0c\u76ae\u75b9\u5e94\u8be5\u4e0d\u4e25\u91cd\uff0c\u5f88\u5feb\u5c31\u4f1a\u6d88\u9000\u3002\u787c\u66ff\u4f50\u7c73\u5f15\u8d77\u7684\u4e25\u91cd\u8fc7\u654f\u53cd\u5e94\u5f88\u5c11\u89c1\uff0c\u76ee\u524d\u5c1a\u65e0\u76f8\u5173\u62a5\u9053\u3002 <\/span><a href=\"https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT00153920\"><span style=\"font-weight: 400;\">\u4e34\u5e8a\u7814\u7a76<\/span><\/a><span style=\"font-weight: 400;\"> \u4e3a\u6d4b\u8bd5\u836f\u7269\u7684\u7597\u6548\u800c\u8fdb\u884c\u7684\u6d4b\u8bd5\u3002\u56e0\u6b64\uff0c\u5982\u679c\u60a8\u51fa\u73b0\u4efb\u4f55\u4e25\u91cd\u7684\u8fc7\u654f\u53cd\u5e94\uff0c\u5e94\u7acb\u5373\u8054\u7cfb\u60a8\u7684\u533b\u751f\u6216\u836f\u5242\u5e08\u3002<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">&nbsp;<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-cost\"><span class=\"ez-toc-section\" id=\"Cost\"><\/span>\u6210\u672c<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">\u787c\u66ff\u4f50\u7c73\u7684\u5e73\u5747\u96f6\u552e\u4ef7\u7ea6\u4e3a\u6bcf\u652f\u9759\u8109\u6ce8\u5c04\u7c89\u5242$1,644\u7f8e\u5143\u3002\u7136\u800c\uff0c\u8bb8\u591a\u56e0\u7d20\u90fd\u4f1a\u5f71\u54cd\u60a8\u7684\u5177\u4f53\u652f\u4ed8\u4ef7\u683c\uff0c\u4f8b\u5982\u60a8\u7684\u6240\u5728\u5730\u3001\u4fdd\u9669\u548c\u533b\u7597\u4fdd\u5065\u8ba1\u5212\u3002<\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u662f\u4e00\u79cd\u5728\u4e16\u754c\u8bb8\u591a\u5730\u533a\u666e\u904d\u5b58\u5728\u7684\u764c\u75c7\u3002\u8fd9\u79cd\u75be\u75c5\u4f1a\u5f71\u54cd\u9aa8\u9ad3\u4e2d\u7684\u6d46\u7ec6\u80de\uff0c\u572860\u5c81\u4ee5\u4e0a\u7684\u7537\u6027\u4e2d\u5f88\u5e38\u89c1\u3002<\/p>","protected":false},"author":23,"featured_media":22436,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[13],"tags":[29],"class_list":["post-22435","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cancer","tag-miralle-kaldass"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Velcade (Bortezomib): A Promising Treatment for Multiple Myeloma<\/title>\n<meta name=\"description\" content=\"Learn about Velcade (Bortezomib), a treatment for multiple myeloma. Topics include how the drug works, administration, and side effects.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/velcade-bortezomib-a-promising-treatment-for-multiple-myeloma\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Velcade (Bortezomib): A Promising Treatment for Multiple Myeloma\" \/>\n<meta property=\"og:description\" content=\"Learn about Velcade (Bortezomib), a treatment for multiple myeloma. Topics include how the drug works, administration, and side effects.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/velcade-bortezomib-a-promising-treatment-for-multiple-myeloma\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-21T17:29:13+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-17T16:29:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/myeloma.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Miralle Kaldass\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Miralle Kaldass\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/velcade-bortezomib-a-promising-treatment-for-multiple-myeloma\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/velcade-bortezomib-a-promising-treatment-for-multiple-myeloma\\\/\"},\"author\":{\"name\":\"Miralle Kaldass\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/b67a794f5dbb4ca54f30cb87e08c065d\"},\"headline\":\"Velcade (Bortezomib): A Promising Treatment for Multiple Myeloma\",\"datePublished\":\"2023-03-21T17:29:13+00:00\",\"dateModified\":\"2025-07-17T16:29:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/velcade-bortezomib-a-promising-treatment-for-multiple-myeloma\\\/\"},\"wordCount\":933,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/velcade-bortezomib-a-promising-treatment-for-multiple-myeloma\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/myeloma.jpg\",\"keywords\":[\"Miralle Kaldass\"],\"articleSection\":[\"Cancer\"],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/velcade-bortezomib-a-promising-treatment-for-multiple-myeloma\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/velcade-bortezomib-a-promising-treatment-for-multiple-myeloma\\\/\",\"name\":\"Velcade (Bortezomib): A Promising Treatment for Multiple Myeloma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/velcade-bortezomib-a-promising-treatment-for-multiple-myeloma\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/velcade-bortezomib-a-promising-treatment-for-multiple-myeloma\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/myeloma.jpg\",\"datePublished\":\"2023-03-21T17:29:13+00:00\",\"dateModified\":\"2025-07-17T16:29:17+00:00\",\"description\":\"Learn about Velcade (Bortezomib), a treatment for multiple myeloma. Topics include how the drug works, administration, and side effects.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/velcade-bortezomib-a-promising-treatment-for-multiple-myeloma\\\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/velcade-bortezomib-a-promising-treatment-for-multiple-myeloma\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/velcade-bortezomib-a-promising-treatment-for-multiple-myeloma\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/myeloma.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/myeloma.jpg\",\"width\":1280,\"height\":853,\"caption\":\"Multiple Myeloma, a type of cancer\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/velcade-bortezomib-a-promising-treatment-for-multiple-myeloma\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Velcade (Bortezomib): A Promising Treatment for Multiple Myeloma\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/b67a794f5dbb4ca54f30cb87e08c065d\",\"name\":\"Miralle Kaldass\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8da1d0d99ef07d2baccce4b8a6cc7c4ec96f35ff229610275075fb1b713e5bcb?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8da1d0d99ef07d2baccce4b8a6cc7c4ec96f35ff229610275075fb1b713e5bcb?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8da1d0d99ef07d2baccce4b8a6cc7c4ec96f35ff229610275075fb1b713e5bcb?s=96&d=mm&r=g\",\"caption\":\"Miralle Kaldass\"},\"description\":\"Miralle Kaldass was born and raised in Egypt. She received her pharmacy degree from the Faculty of Pharmacy, Cairo University, and has 5 years of experience as a pharmacist. The most rewarding part of her job is providing patient care where a patient's health can improve and allow them to live a better life. Her areas of expertise include long-term care with nursing homes and hospices, specialty pharmacy, and TPN. In her free time, she enjoys going to the gym, shopping, and walking by the beach.\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/author\\\/miralle\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Velcade (Bortezomib)\uff1a\u4e00\u79cd\u6709\u524d\u666f\u7684\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u6cbb\u7597\u65b9\u6cd5","description":"\u4e86\u89e3\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u6cbb\u7597\u836f\u7269Velcade (Bortezomib)\u3002\u4e3b\u9898\u5305\u62ec\u8be5\u836f\u7269\u7684\u4f5c\u7528\u673a\u5236\u3001\u7528\u6cd5\u7528\u91cf\u548c\u526f\u4f5c\u7528\u3002","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/velcade-bortezomib-a-promising-treatment-for-multiple-myeloma\/","og_locale":"zh_CN","og_type":"article","og_title":"Velcade (Bortezomib): A Promising Treatment for Multiple Myeloma","og_description":"Learn about Velcade (Bortezomib), a treatment for multiple myeloma. Topics include how the drug works, administration, and side effects.","og_url":"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/velcade-bortezomib-a-promising-treatment-for-multiple-myeloma\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2023-03-21T17:29:13+00:00","article_modified_time":"2025-07-17T16:29:17+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/myeloma.jpg","type":"image\/jpeg"}],"author":"Miralle Kaldass","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Miralle Kaldass","Est. reading time":"5 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/velcade-bortezomib-a-promising-treatment-for-multiple-myeloma\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/velcade-bortezomib-a-promising-treatment-for-multiple-myeloma\/"},"author":{"name":"Miralle Kaldass","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/b67a794f5dbb4ca54f30cb87e08c065d"},"headline":"Velcade (Bortezomib): A Promising Treatment for Multiple Myeloma","datePublished":"2023-03-21T17:29:13+00:00","dateModified":"2025-07-17T16:29:17+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/velcade-bortezomib-a-promising-treatment-for-multiple-myeloma\/"},"wordCount":933,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/velcade-bortezomib-a-promising-treatment-for-multiple-myeloma\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/myeloma.jpg","keywords":["Miralle Kaldass"],"articleSection":["Cancer"],"inLanguage":"zh-Hans"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/velcade-bortezomib-a-promising-treatment-for-multiple-myeloma\/","url":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/velcade-bortezomib-a-promising-treatment-for-multiple-myeloma\/","name":"Velcade (Bortezomib)\uff1a\u4e00\u79cd\u6709\u524d\u666f\u7684\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u6cbb\u7597\u65b9\u6cd5","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/velcade-bortezomib-a-promising-treatment-for-multiple-myeloma\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/velcade-bortezomib-a-promising-treatment-for-multiple-myeloma\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/myeloma.jpg","datePublished":"2023-03-21T17:29:13+00:00","dateModified":"2025-07-17T16:29:17+00:00","description":"\u4e86\u89e3\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u6cbb\u7597\u836f\u7269Velcade (Bortezomib)\u3002\u4e3b\u9898\u5305\u62ec\u8be5\u836f\u7269\u7684\u4f5c\u7528\u673a\u5236\u3001\u7528\u6cd5\u7528\u91cf\u548c\u526f\u4f5c\u7528\u3002","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/velcade-bortezomib-a-promising-treatment-for-multiple-myeloma\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/es\/cancer\/velcade-bortezomib-a-promising-treatment-for-multiple-myeloma\/"]}]},{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/velcade-bortezomib-a-promising-treatment-for-multiple-myeloma\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/myeloma.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/myeloma.jpg","width":1280,"height":853,"caption":"Multiple Myeloma, a type of cancer"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/velcade-bortezomib-a-promising-treatment-for-multiple-myeloma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/es\/"},{"@type":"ListItem","position":2,"name":"Velcade (Bortezomib): A Promising Treatment for Multiple Myeloma"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/#website","url":"https:\/\/ameripharmaspecialty.com\/","name":"AmeriPharma\u00ae \u4e13\u4e1a\u62a4\u7406","description":"AmeriPharma \u7684\u4e13\u4e1a\u62a4\u7406","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/#organization","name":"\u7f8e\u56fd\u5236\u836f\u4e13\u4e1a\u62a4\u7406","url":"https:\/\/ameripharmaspecialty.com\/","logo":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/b67a794f5dbb4ca54f30cb87e08c065d","name":"\u7c73\u62c9\u52d2\u00b7\u5361\u5c14\u8fbe\u65af","image":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/secure.gravatar.com\/avatar\/8da1d0d99ef07d2baccce4b8a6cc7c4ec96f35ff229610275075fb1b713e5bcb?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8da1d0d99ef07d2baccce4b8a6cc7c4ec96f35ff229610275075fb1b713e5bcb?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8da1d0d99ef07d2baccce4b8a6cc7c4ec96f35ff229610275075fb1b713e5bcb?s=96&d=mm&r=g","caption":"Miralle Kaldass"},"description":"Miralle Kaldass \u5728\u57c3\u53ca\u51fa\u751f\u957f\u5927\u3002\u5979\u6bd5\u4e1a\u4e8e\u5f00\u7f57\u5927\u5b66\u836f\u5b66\u9662\uff0c\u83b7\u5f97\u836f\u5b66\u5b66\u4f4d\uff0c\u5e76\u62e5\u6709\u4e94\u5e74\u7684\u836f\u5242\u5e08\u7ecf\u9a8c\u3002\u5979\u5de5\u4f5c\u4e2d\u6700\u6709\u6210\u5c31\u611f\u7684\u90e8\u5206\u662f\u4e3a\u60a3\u8005\u63d0\u4f9b\u62a4\u7406\uff0c\u5e2e\u52a9\u60a3\u8005\u6539\u5584\u5065\u5eb7\u72b6\u51b5\uff0c\u8fc7\u4e0a\u66f4\u7f8e\u597d\u7684\u751f\u6d3b\u3002\u5979\u7684\u4e13\u4e1a\u9886\u57df\u5305\u62ec\u7597\u517b\u9662\u548c\u4e34\u7ec8\u5173\u6000\u673a\u6784\u7684\u957f\u671f\u62a4\u7406\u3001\u4e13\u4e1a\u836f\u623f\u4ee5\u53ca TPN \u5de5\u4f5c\u3002\u95f2\u6687\u65f6\uff0c\u5979\u559c\u6b22\u53bb\u5065\u8eab\u623f\u3001\u8d2d\u7269\u548c\u5728\u6d77\u8fb9\u6563\u6b65\u3002","url":"https:\/\/ameripharmaspecialty.com\/zh\/author\/miralle\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/myeloma.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/myeloma-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/myeloma-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/myeloma-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/myeloma-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/myeloma.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/myeloma.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/myeloma.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/myeloma.jpg",600,400,false],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/myeloma-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/myeloma-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/myeloma-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/myeloma-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/myeloma-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/myeloma-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/myeloma-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/myeloma.jpg",1280,853,false]},"uagb_author_info":{"display_name":"Miralle Kaldass","author_link":"https:\/\/ameripharmaspecialty.com\/zh\/author\/miralle\/"},"uagb_comment_info":0,"uagb_excerpt":"Multiple myeloma is a type of cancer prevalent in many parts of the world. This condition affects the plasma cells in bone marrow and is common among male adults over 60.","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/myeloma.jpg",1280,853,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/myeloma.jpg",1280,853,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/myeloma.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/myeloma-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/myeloma-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/myeloma-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/myeloma.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/myeloma.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/myeloma.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/myeloma.jpg",600,400,false],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/myeloma-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/myeloma-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/myeloma-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/myeloma-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/myeloma-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/myeloma-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/myeloma-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/myeloma.jpg",1280,853,false]},"rttpg_author":{"display_name":"Miralle Kaldass","author_link":"https:\/\/ameripharmaspecialty.com\/zh\/author\/miralle\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/zh\/category\/cancer\/\" rel=\"category tag\">Cancer<\/a>","rttpg_excerpt":"Multiple myeloma is a type of cancer prevalent in many parts of the world. This condition affects the plasma cells in bone marrow and is common among male adults over 60.","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/posts\/22435","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/users\/23"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/comments?post=22435"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/posts\/22435\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/media\/22436"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/media?parent=22435"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/categories?post=22435"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/tags?post=22435"}],"curies":[{"name":"\u53ef\u6e7f\u6027\u7c89\u5242","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}